Early subclinical stages of the inflammatory bowel diseases: insights from human and animal studies
American Journal of Physiology-Gastrointestinal and Liver Physiology · 01.01.2025 · 328 (1) · G17-G31
DOI: 10.1152/ajpgi.00252.2024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, erschienen am 01.01.2025. Verfasst von Cecelia Kelly und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics and Microbiology, Duke Microbiome Center, Duke University School of Medicine, Durham, North Carolina, United States. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Disease Models, Animal, Gastrointestinal Microbiome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, HHS | National Institutes of Health (NIH).
Abstract (Originalsprache)
The inflammatory bowel diseases (IBD) occur in genetically susceptible individuals that mount inappropriate immune responses to their microbiota leading to chronic intestinal inflammation. The natural history of IBD progression begins with early subclinical stages of disease that occur before clinical diagnosis. Improved understanding of those early subclinical stages could lead to new or improved strategies for IBD diagnosis, prognostication, or prevention. Here, we review our current understanding of the early subclinical stages of IBD in humans including studies from first-degree relatives of patients with IBD and members of the general population who go on to develop IBD. We also discuss representative mouse models of IBD that can be used to investigate disease dynamics and host-microbiota relationships during these early stages. In particular, we underscore how mouse models of IBD that develop disease later in life with variable penetrance may present valuable opportunities to discern early subclinical mechanisms of disease before histological inflammation and other severe symptoms become apparent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Genetics and Microbiology, Duke Microbiome Center, Duke University School of Medicine, Durham, North Carolina, United States.
- Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States.
- Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, United States.
ORCID-Profile: Cecelia Kelly, John F Rawls
Förderung
- NIDDK NIH HHS
- HHS | National Institutes of Health (NIH)
Zitieren
APA
Kelly, C., Sartor, R. B., & Rawls, J. F. (2025). Early subclinical stages of the inflammatory bowel diseases: insights from human and animal studies. American Journal of Physiology-Gastrointestinal and Liver Physiology, 328(1), G17-G31. https://doi.org/10.1152/ajpgi.00252.2024
Vancouver
Kelly C, Sartor RB, Rawls JF. Early subclinical stages of the inflammatory bowel diseases: insights from human and animal studies. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2025;328(1):G17-G31. doi:10.1152/ajpgi.00252.2024
BibTeX
@article{Kelly2025,
author = {Kelly, Cecelia and Sartor, R Balfour and Rawls, John F},
title = {Early subclinical stages of the inflammatory bowel diseases: insights from human and animal studies},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2025},
volume = {328},
number = {1},
pages = {G17--G31},
doi = {10.1152/ajpgi.00252.2024}
}
EUVIMED